Publications by authors named "Luca Franceschini"

Claim this Profile
T
The Strange Case of Functional High-Risk Multiple Myeloma Patients: Is It Possible to Identify Them in Clinical Practice?
Sonia Morè, Massimo Offidani, Laura Corvatta, Tommaso Za, Francesca Fazio, Luca Franceschini

Cancers (Basel)· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sustained remission in relapsed/refractory diffuse large B cell lymphoma following Glofitamab discontinuation due to JC virus reactivation: balancing efficacy and infectious risk.
Massimiliano Marinoni, Lucrezia De Marchi, Federico Meconi, Alice Di Rocco, Luca Franceschini

Curr Res Transl Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection events in patients with newly diagnosed multiple myeloma with anti-CD38 monoclonal antibody-based first line regimens: A multicentric Italian experience.
Angela Rago, Francesca Fioritoni, Carmine Liberatore, Stefano Pulini, Francesca Fazio, Luca Franceschini

Ann Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cytogenetic Features and Their Implications in Clinical Practice: A Real-World Analysis of a Large Cohort of Multiple Myeloma Patients.
Sonia Morè, Massimo Offidani, Laura Corvatta, Silvia Aloisi, Tommaso Za, Luca Franceschini

Clin Lymphoma Myeloma Leuk· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges in Multiple Myeloma Therapy in Older and Frail Patients.
Anna Aureli, Beatrice Marziani, Tommaso Sconocchia, Gianmario Pasqualone, Luca Franceschini

Cancers (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Survival with Multiple Myeloma: An Italian Experience.
Francesca Fazio, Martina Gherardini, Elena Rossi, Tommaso Za, Francesca Di Landro, Luca Franceschini

Cancers (Basel)· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow-up of a multicenter, retrospective real-world experience with 321 cases outside of controlled clinical trials.
Enrica Antonia Martino, Salvatore Palmieri, Monica Galli, Daniele Derudas, Roberto Mina, Luca Franceschini

Hematol Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A tryptophan metabolite prevents depletion of circulating endothelial progenitor cells in systemic low-grade inflammation.
Massimo R Mannarino, Vanessa Bianconi, Giulia Scalisi, Luca Franceschini, Giorgia Manni

Front Immunol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus for Flow Cytometry Clinical Report on Multiple Myeloma: A Multicenter Harmonization Process Merging Laboratory Experience and Clinical Needs.
Iole Cordone, Rachele Amodeo, Silvia Bellesi, Fiorella Bottan, Francesco Buccisano, Luca Franceschini

Cancers (Basel)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daratumumab combined with dexamethasone and lenalidomide or bortezomib in relapsed/refractory multiple myeloma (RRMM) patients: Report from the multiple myeloma GIMEMA Lazio group.
Francesca Fazio, Luca Franceschini, Valeria Tomarchio, Angela Rago, Maria Grazia Garzia

EJHaem· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New insight into the catalytic -dependent and -independent roles of METTL3 in sustaining aberrant translation in chronic myeloid leukemia.
Zaira Ianniello, Melissa Sorci, Lavinia Ceci Ginistrelli, Alessia Iaiza, Marcella Marchioni, Luca Franceschini

Cell Death Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence, persistence and efficacy of dasatinib and nilotinib in the treatment of patients resistant or intolerant to imatinib with chronic myeloid leukemia in chronic phase: an Italian multicenter study over two years in real life.
Fiorenzo Santoleri, Elena Ranucci, Gaetano La Barba, Irene Colasanto, Matilde Scaldaferri, Luca Franceschini

Curr Med Res Opin· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early detection of IgH monoclonal rearrangement in follicular spicules of the nose preceding multiple myeloma diagnosis.
Mauro Mazzeo, Cosimo Di Raimondo, Carmelo Gurnari, Maria Cristina Rapanotti, Alessandro Giunta, Luca Franceschini

G Ital Dermatol Venereol· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations.
Carmelo Gurnari, Anna M Lombardi, Elisabetta Cosi, Giacomo Biagetti, Francesco Buccisano, Luca Franceschini

Br J Haematol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Digital PCR improves the quantitation of DMR and the selection of CML candidates to TKIs discontinuation.
Simona Bernardi, Michele Malagola, Camilla Zanaglio, Nicola Polverelli, Elif Dereli Eke, Luca Franceschini

Cancer Med· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of IFN lambda 3/4 single nucleotide polymorphisms on the cytomegalovirus reactivation in autologous stem cell transplant patients.
Ombretta Annibali, Livia Piccioni, Valeria Tomarchio, Erika Circhetta, Chiara Sarlo, Luca Franceschini

PLoS One· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nephelometric assay of urine free light chains: an alternative and early clinical test for Bence-Jones protein quantification.
Massimo Pieri, Stefano Pignalosa, Luca Franceschini, Manuela Rizzo, Maria Cantonetti

Clin Chem Lab Med· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy.
Laura Cicconi, Massimo Breccia, Luca Franceschini, Roberto Latagliata, Matteo Molica

Ann Hematol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent Sweet's syndrome in a patient with multiple myeloma.
Carmelo Gurnari, Luca Franceschini, Lucia Anemona, Francesca Passarelli, Sara Vaccarini

Clin Case Rep· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal detection of DNMT3A transcripts in patients with acute myeloid leukemia.
Tiziana Ottone, Valentina Alfonso, Licia Iaccarino, Syed Khizer Hasan, Melissa Mancini, Luca Franceschini

Am J Hematol· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia.
Carmelo Gurnari, Paola Panetta, Emiliano Fabiani, Anna Maria Nardone, Diana Postorivo, Luca Franceschini

Mol Clin Oncol· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal tumour burden in haematological diseases: a step forward with quantitative assessment of Bence-Jones in nephelometry?
Massimo Pieri, Alessandro De Stefano, Luca Franceschini, Manuela Rizzo, Fabio Duranti

Br J Haematol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dasatinib first-line: Multicentric Italian experience outside clinical trials.
Massimo Breccia, Fabio Stagno, Luigiana Luciano, Elisabetta Abruzzese, Mario Annunziata, Luca Franceschini

Leuk Res· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-treatment staging of multiple myeloma patients: comparison of whole-body diffusion weighted imaging with whole-body T1-weighted contrast-enhanced imaging.
Ettore Squillaci, Francesca Bolacchi, Simone Altobelli, Luca Franceschini, Alberto Bergamini

Acta Radiol· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network.
Francesco Marchesi, Elisabetta Cerchiara, Maria Laura Dessanti, Svitlana Gumenyuk, Luca Franceschini

Br J Haematol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis